The Latest Research From Our Experts
- Whitepaper
Genetic counseling plays a critical role in accurately interpreting genetic test results, guiding decision-making for both patients and providers. Unfortunately, there are a limited number of genetic counselors. The answer lies in outsourcing genetic services as a way of tapping into external expertise and enhancing operational efficiency. This approach not only alleviates the burden on […]
- Life Sciences, Whitepaper
Patient diversity and inclusion are essential to rare disease research progress. Why? Because people with the same disease may experience it differently. With a US population comprised of 40% racial and ethnic minorities[1],it’s essential that clinical trials reflect a variety of lived experiences, as well as characteristics like ethnicity, age, and gender, so that all […]
- Life Sciences, Whitepaper
To date, 760 orphan drugs have been approved by US and European agencies to treat nearly 7,000 identified rare diseases. With 80% having a genetic component, genetic testing and the use of its data have become essential ingredients to the successful diagnosis and treatment of rare diseases. Yet incorporating that genetic data into the clinical […]
- Case Study
As the demand for genetic counseling continues to rise, many health systems struggle to meet the needs of their patients. Delays in genetic counseling can have significant impacts, particularly for cancer patients where timely results are crucial. The National Society for Genetic Counselors (NSGC) estimates there are currently 5,629 genetic counselors in North America. With […]
How can we help?
Reach out today to discover how our dynamic solutions can help your organization make informed decisions, manage utilization of genetic tests, and control costs for cost-effective enhanced patient care and better outcomes for all.
